Document: Marketing authorisation application (MAA) - pre-submission interactions form-2025/7/23

Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes-2025/9/8

Document: ICH M14 guideline on general principles on planning, designing, analysing, and reporting of non-interventional studies that utilise real-world data for safety assessment of medicines Step 5-2025/10/10

Page: Scientific advice and protocol assistance-2025/11/17

Page: Stability testing for applications for variations to marketing authorisation - Scientific guideline-2025/12/12

国家药监局关于暂停进口、销售和使用Supriya Lifescience Ltd.马来酸氯苯那敏原料药的公告（2026年第14号） -2026/1/26

Document: Darwin EU study: Background incidence rates of selected vaccine adverse events of special in Europe-2026/3/4

Page: Paediatric addendum to the guideline on clinical investigation of medicinal products for the treatment of pulmonary arterial hypertension - Scientific guideline-2026/3/31

Development of Local Anesthetic Drug Products With Prolonged Duration of Effect-2026/5/13

Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus-2026/6/29